Viking Therapeutics Earnings
NASDAQ: VKTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Oct 28, 2026
Fiscal period
Sep/2026
EPS estimate
$1.00
Viking Therapeutics earnings summary
Viking Therapeutics is scheduled to report Sep/2026 earnings on Oct 28, 2026, with analysts expecting EPS of $1.00. In its most recent report on Jul 29, 2026 (Q2 2026), VKTX posted EPS of $-1.10. Revenue for the quarter was $0.
Across the last 16 reports, VKTX shares moved an average of 8.7% (in either direction) in the first trading session after results, rising 12 times and falling 4 times.
Summary generated from market data by MetaCap's automated system. Methodology
VKTX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 29, 2026 | — | $-1.10 | — | +7.9% |
| Apr 30, 2026 | — | $-1.37 | — | +4.4% |
| Feb 11, 2026 | — | $-1.39 | — | +7.0% |
| Oct 23, 2025 | — | $-0.81 | — | +10.6% |
| Jul 23, 2025 | — | $-0.58 | — | -5.1% |
| Apr 24, 2025 | — | $-0.41 | — | +17.5% |
| Feb 26, 2025 | — | $-0.33 | — | +0.8% |
| Oct 23, 2024 | — | $-0.22 | — | -6.6% |
| Jul 24, 2024 | — | $-0.20 | — | -19.6% |
| Apr 25, 2024 | — | $-0.26 | — | +3.6% |
| Feb 7, 2024 | — | $-0.24 | — | +18.4% |
| Oct 25, 2023 | — | $-0.23 | — | +14.2% |
| Jul 26, 2023 | — | $-0.19 | — | -9.3% |
| Apr 26, 2023 | — | $-0.25 | — | +7.3% |
| Feb 10, 2023 | — | $-0.25 | — | +5.8% |
| Oct 26, 2022 | — | $-0.21 | — | +1.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.